Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients

This publication has 63 references indexed in Scilit:

• Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
  The Lancet, 2004
• Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
  The Lancet, 2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled Trial
  JAMA, 2001
• Pravastatin Therapy and the Risk of Stroke
  New England Journal of Medicine, 2000
• Effect of HMGcoA Reductase Inhibitors on Stroke
  Annals of Internal Medicine, 1998
• Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality
  JAMA, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts
  The Lancet, 1995
• Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial
  New England Journal of Medicine, 1989